Binding investigation of human 5-lipoxygenase with its inhibitors by SPR technology correlating with molecular docking simulation

被引:31
作者
Du, Li
Zhang, Zhenshan
Luo, Xiaomin
Chen, Kaixian
Shen, Xu [1 ]
Jiang, Hualiang
机构
[1] Chinese Acad Sci, Grad Sch, Shanghai Inst Mat Med,State Key Lab Drug Res, Shanghai Inst Biol Sci,Drug Discovery & Design Ct, Shanghai 201203, Peoples R China
[2] E China Univ Sci & Technol, Sch Pharm, Shanghai 200237, Peoples R China
基金
中国国家自然科学基金;
关键词
arachidonic acid; 5-lipoxygenase inhibitors; molecular docking; surface plasmon resonance (SPR);
D O I
10.1093/jb/mvj084
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The binding features of a series of 5-lipoxygenase (5-LOX) inhibitors (caffeic acid, NDGA, AA-861, CDC, esculetin, gossypol and phenidone) to human 5-LOX have been studied by using surface plasmon resonance biosensor (SPR) technology based Biacore 3000 and molecular docking simulation analyses. The SPR results showed that the equilibrium dissociation constant (K-D) values evaluated by Biacore 3000 for the inhibitors showed a good correlation with its reported IC50, suggesting that SPR technology might be applicable as a direct assay method in screening new 5-LOX inhibitors at an early stage. In addition, the 3D structural model of 5-LOX was generated according to the crystal structure of rabbit reticulocyte 15-lipoxygenase, and the molecular docking simulation analyses revealed that the predicted binding free energies for the inhibitors correlated well with the K-D values measured by SPR assay, which implies the correctness of the constructed 3D structural model of 5-LOX. This current work has potential for application in structure-based 5-LOX inhibitor discovery.
引用
收藏
页码:715 / 723
页数:9
相关论文
共 52 条
[41]  
2-E]
[42]  
Steele VE, 1999, CANCER EPIDEM BIOMAR, V8, P467
[43]  
TAVARES IA, 1993, INT J TISSUE REACT, V15, P49
[44]   CLUSTAL-W - IMPROVING THE SENSITIVITY OF PROGRESSIVE MULTIPLE SEQUENCE ALIGNMENT THROUGH SEQUENCE WEIGHTING, POSITION-SPECIFIC GAP PENALTIES AND WEIGHT MATRIX CHOICE [J].
THOMPSON, JD ;
HIGGINS, DG ;
GIBSON, TJ .
NUCLEIC ACIDS RESEARCH, 1994, 22 (22) :4673-4680
[45]   The mechanism of action of the new antiinflammatory compound ML3000: inhibition of 5-LOX and COX-1/2 [J].
Tries, S ;
Neupert, W ;
Laufer, S .
INFLAMMATION RESEARCH, 2002, 51 (03) :135-143
[46]  
*TRIP ASS, 2001, SYB VERS 6 8
[47]  
UEDA N, 1986, J BIOL CHEM, V261, P7982
[48]  
Vinter J G, 1987, J Comput Aided Mol Des, V1, P31, DOI 10.1007/BF01680556
[49]   LIGPLOT - A PROGRAM TO GENERATE SCHEMATIC DIAGRAMS OF PROTEIN LIGAND INTERACTIONS [J].
WALLACE, AC ;
LASKOWSKI, RA ;
THORNTON, JM .
PROTEIN ENGINEERING, 1995, 8 (02) :127-134
[50]  
YOSHIMOTO T, 1982, BIOCHIM BIOPHYS ACTA, V713, P470